This is a working overview of Research material, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-11-24 and is reviewed periodically as new material appears.
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C62H98N16O22 | Computed for the free peptide |
| Monoisotopic mass | Approximately 1419 Da | Reported values shift with counterion and hydration |
| Residue count | 15 amino acids | Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Origin | Fragment of human gastric juice protein | First described in early 1990s research reports |
| Common synonyms | BPC 157; PL 14736; bepecin | Naming varies across papers and catalogues |
Within the research literature, the peptide is discussed through several provisional mechanisms, including cytoprotection, modulation of growth factor signaling, and interaction with the nitric oxide system. None of these mechanisms is fully characterized, and no single pathway is universally accepted. Review articles typically note the gap between consistent animal findings and sparse human evidence. The compound is classified as a research chemical rather than an approved pharmaceutical, which shapes how studies are designed, funded, and reported.
BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, corresponding to a partial fragment of a larger protein detected in human gastric juice. The name derives from the parent protein designation BPC, an abbreviation of body protection compound, with 157 acting as a fraction or batch identifier used by the original investigators. Its molecular weight is approximately 1419 daltons, and the chain contains no unusual residues or disulfide bridges. In the literature it is described as a short, water-soluble fragment rather than a complete natural protein.
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.
Confirmation of identity and purity relies on standard peptide analysis techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and serves as the most common purity assay. Mass spectrometry, often coupled to that chromatography step, provides an accurate molecular mass that can be matched against the expected value. Amino acid analysis or sequencing can be added for further confirmation. Because short peptides can be produced by different synthetic routes, laboratories usually report both a chromatographic purity percentage and a mass confirmation rather than a single figure.
BPC-157 is commonly supplied as a lyophilized powder, a freeze-dried solid that is reconstituted before use in laboratory work. As a short peptide, it dissolves readily in water and in aqueous buffer solutions, and stock solutions are typically prepared in water or a mild buffer. The chain contains several proline and acidic residues, which influence how it behaves in solution. Because the solid can take up moisture, weighing and handling are usually performed under low-humidity conditions. Its solubility class is described as freely soluble in water rather than requiring an organic solvent.
Laboratory research on this peptide has examined a wide and heterogeneous set of endpoints, including gastric ulcer models, tendon and ligament injury, wound closure, and intestinal inflammation. Most published findings come from rodent studies, and reported effect sizes are often large relative to controls. Because the compound has been tested across many unrelated injury models, the literature is frequently described as unusually broad for a single peptide. A substantial share of this work originates from a small number of research groups, which matters when assessing how widely results have been reproduced.
Evidence in humans is limited. Small clinical studies have examined the peptide in contexts such as ulcerative colitis and wound healing, but participant numbers are small and independent replication is scarce. It is not approved as a medicine by major regulatory agencies and is distributed mainly as a research material or compounded preparation. Long-term human safety data are not established, and questions about absorption through non-injected routes remain open rather than resolved. Claims about its effects are best read against these gaps.
Penn Station is configured with 11 platforms, 21 tracks, and four interlockings. The station's platforms and tracks are numbered from south to north. Tracks 1–4 are stub-end tracks ending at the eastern end of the platform and are used exclusively by NJ Transit, as they do not connect to the East River Tunnels. The remaining tracks 5 through 21 are through tracks with connections at both ends. In normal operations, Amtrak and NJ Transit share tracks 5–12, all three railroads share tracks 13–16, and the LIRR has the exclusive use of tracks 17–21 on the north side of the station. The station is accessed via seven single-track tunnels: two North River Tunnels under the Hudson River, four East River Tunnels under the East River, and one shorter Empire Tunnel under the West Side of Manhattan. Each under-river tunnel is approximately 3 miles long, while the Empire Tunnel is approximately 0.3 miles long. The interlockings that control the station complex are designated 'A', 'C', 'JO', and 'KN'. On the west side of the station, 'A' and 'KN' interlockings route trains to and from the North River Tunnels, the Empire Tunnel, and the West Side Yard. On the east side, two interlockings ('C' and 'JO') route trains to and from the four East River tunnels; each interlocking connects two of the tunnel tracks to only 17 of the 21 platform tracks, as tracks 1–4 do not connect to the east.
Through dietary modification involving the adjustment of menu choices of affected persons from available food sources to optimize vitamin A content. Enriching commonly eaten and affordable foods with vitamin A, a process called fortification. It involves the addition of synthetic vitamin A to staple foods like margarine, bread, flour, cereals, and infant formula during processing. By giving high doses of vitamin A to the targeted deficient population, a method known as supplementation. In regions where deficiency is common, a single large dose is recommended to those at high risk twice a year. Retinol is also used to reduce the risk of complications in measles patients.
During the time leading up to the passing of the laws, there was fierce opposition to them, above all by the Free Democratic Party, the rising West German student movement, a group calling itself Notstand der Demokratie ("Democracy in Crisis") and members of the Campaign against Nuclear Armament. A key event in the development of open democratic debate occurred in 1967, when the Shah of Iran, Mohammad Reza Pahlavi, visited West Berlin. Several thousand demonstrators gathered outside the Opera House where he was to attend a special performance. Supporters of the Shah (later known as Jubelperser), armed with staves and bricks attacked the protesters while the police stood by and watched. A demonstration in the centre was being forcibly dispersed when a bystander named Benno Ohnesorg was shot in the head and killed by a plainclothes policeman. (It has now been established that the policeman, Kurras, was a paid spy of the East German security forces.) Protest demonstrations continued, and calls for more active opposition by some groups of students were made. In a massive campaign against the protesters, the press, especially the tabloid Bild-Zeitung newspaper, described these as a massive disruption to life in Berlin. Protests against the US intervention in Vietnam, mingled with anger over the vigour with which demonstrations were repressed led to mounting militance among the students at the universities in Berlin.
== Carrier proteins == Albumin, carries thyroid hormones and other hormones, particularly fat soluble ones, fatty acids to the liver, unconjugated bilirubin, many drugs and Ca2+ Ceruloplasmin, carries copper Transcortin, carries cortisol, aldosterone and progesterone Haptoglobin, carries free hemoglobin released from erythrocytes Hemopexin, carries free heme released from hemoglobin IGF binding protein, carries insulin-like growth factor 1 Major urinary proteins, carries pheromones in rodents Retinol binding protein, carries retinol Sex hormone-binding globulin, carries sex hormones, specifically testosterone and estradiol Thyroxine-binding globulin, carries the thyroid hormones thyroxine (T4) and 3,5,3’-triiodothyronine (T3) Transthyretin, carries the thyroid hormone thyroxine (T4) Transferrin, carries iron ions in the ferric form (Fe3+) Vitamin D-binding protein, carries vitamin D
Sources: en.wikipedia.org
=== Pulmonary involvement === The lungs are commonly affected in MCTD, with around 75% of patients having lung involvement. The most prevalent pulmonary complications of MCTD are interstitial lung disease (ILD) and pulmonary hypertension; however, a wide spectrum of other pulmonary problems have been recorded, including pleural effusions, pleuritic discomfort, alveolar hemorrhage, and thromboembolic illness. Early indications of pulmonary involvement include dyspnea, dry cough, and pleuritic chest pain.
== Pre-trial proceedings == The first evidence that the prosecution introduced against Agüero, was immediately after her arrest, alleging that Agüero was behind every case, both deaths and decompensations, and that Agüero herself was in the place of the incidents, further alleging that she was the one who notified the doctors and other medical personnel that an emergency with a newborn was underway. On the same day that the prosecution introduced their first accusation, the court in charge of the pre-trial procedures, ordered psychiatric and psychological evaluations of Agüero, to later dictate pre-trial detention. In January 2023, the psychiatric evaluators determined that Agüero knows right from wrong and that she does not suffer from any mental disorder. The psychiatrists further argued that Agüero tried to "manipulate the interview" and that she has difficulties in regards to feeling what others do. After the evaluation, Agüero's indictment was confirmed. The prosecution alleged that in November 2021, Agüero searched on Google "how to dose potassium and insulin injections in newborns." Agüero denied that she searched "how to apply potassium injections" on Google and alleged that she does not have the knowledge to perform such a procedure. Another accusation argued that Agüero concealed the syringes with which she allegedly injected the babies with potassium, under her sleeves, with other medical personnel noting that she went to work with long-sleeved shirts even on hot summer days.
Severe amoebic colitis: Fulminant amoebic colitis is associated with high case fatality and can occur in patients infected with the parasite Entamoeba histolytica after exposure to corticosteroid medications. Neuropsychiatric: steroid psychosis, and anxiety, depression. Therapeutic doses may cause a feeling of artificial well-being known as "steroid euphoria". Rare case reports of corticosteroid misuse, addiction, and dependence due to euphoria exist. The neuropsychiatric effects are partly mediated by sensitization of the body to the actions of adrenaline. Therapeutically, the bulk of corticosteroid dose is given in the morning to mimic the body's diurnal rhythm; if given at night, the feeling of being energized will interfere with sleep. An extensive review is provided by Flores and Gumina. Cardiovascular: Corticosteroids can cause sodium retention through a direct action on the kidney, in a manner analogous to the mineralocorticoid aldosterone. This can result in fluid retention and hypertension. Metabolic: Corticosteroids cause a movement of body fat to the face and torso, resulting in "moon face", "buffalo hump", and "pot belly" or "beer belly", and cause movement of body fat away from the limbs. This has been termed corticosteroid-induced lipodystrophy. Due to the diversion of amino-acids to glucose, they are considered anti-anabolic, and long term therapy can cause muscle wasting (muscle atrophy).
However, they are not true benign neoplasms (denoted by suffix ~oma), which are similar in appearance but very rare in the mouth. Fibrous epulis are fibroepithelial polyps located only on the gingivae. Pyogenic granuloma and pregnancy epulis are both vascular rather than fibrous epulides with more dilated blood vessels making them appear darker pink or red in colour, and soft. They may develop more fibrous as they mature. The pregnancy variant only appears in pregnancy, usually due to plaque and should resolve with better oral hygiene and at the end of the pregnancy if not. Pyogenic granuloma may occur elsewhere in the mouth such as the tongue and lips, but are not therefore epulides. Giant cell epulis, also known as peripheral giant cell granuloma, are like fibrous epulis and occur at the anterior interdental margin, the gum between the teeth at the front. They are more common in females. They are often soft round and deep red to purplish blue. It is important they are investigated to make are they are not true giant cell granuloma. Papilliary hyperplasia of the palate, or epulis fissaratum/denture-induced hyperplasia. The cause may be unknown, but there is an association with ill-fitting dentures resulting in irritation to the mucosa, usually by overextended flange, and with poor denture or oral hygiene. Oral thrush can be present but is not thought to be the cause.
However, Kc will vary with ionic strength. If it is measured at a series of different ionic strengths, the value can be extrapolated to zero ionic strength. The concentration quotient obtained in this manner is known, paradoxically, as a thermodynamic equilibrium constant. Before using a published value of an equilibrium constant in conditions of ionic strength different from the conditions used in its determination, the value should be adjusted.
Sources: en.wikipedia.org
27 April An estimated battalion of PAVN assaulted a night defensive position of a unit of the 2nd Brigade, 25th Infantry Division 10 km northeast of Trảng Bàng. The attack was repulsed with 100 PAVN/VC killed and one captured and 32 individual and 23 crew-served weapons captured; U.S. losses were ten killed. A grass fire spread to the Marines/Navy ammunition supply point 1 near Hill 327 causing a massive explosion and fire.
== History == Metropolis was founded by Dr. Sushil Kanubhai Shah in 1980. The healthcare company was started as a single diagnostic laboratory in Mumbai. Shah's daughter, Ameera Shah, took over the pathology business in 2001. The company started out by partnering with local and regional diagnostic chains, thereby spreading its reach across the country. Metropolis Healthcare has expanded into new service areas, like Clinical Research, Hospital Lab Management and Wellness Solutions, in the past decade. Metropolis Healthcare began its international expansion in 2005 with Sri Lanka being the first market. It further expanded to UAE in 2006, followed by Kenya in 2013 and Mauritius and Ghana in 2014. In February 2018, Metropolis partnered with National Aids Control Organisation (NACO) for a three-year project for diagnosis of HIV at 560 locations in India. As of 2018, the diagnostic chain consists of 124 clinical laboratories and 2400 blood collection centers across India, Ghana, Kenya, Zambia, Uganda, Mauritius and Sri Lanka. In October 2019, Metropolis Healthcare acquired four individual laboratories, Doctor's Clinical Laboratory, Iyer Pathology Laboratory, Nagar Pathology Laboratory and Yash Clinical Laboratory, a subsidiary of Dr Lal PathLabs in Surat, Gujarat, for INR 18 crore. The acquisition was done in order to expand the penetration of Metropolis's wholly owned subsidiary Desai Laboratories. In October 2021, Metropolis completed the acquisition of South Indian diagnostic chain Hitech Diagnostic Centre and its subsidiary Centralab Healthcare Services for ₹636 crore.
Functional or homology screening strategies have been used to identify genes that produce small bioactive molecules. Functional metagenomic studies are designed to search for specific phenotypes that are associated with molecules with specific characteristics. Homology metagenomic studies, on the other hand, are designed to examine genes to identify conserved sequences that are previously associated with the expression of biologically active molecules. Functional metagenomic studies enable the discovery of novel genes that encode biologically active molecules. These assays include top agar overlay assays where antibiotics generate zones of growth inhibition against test microbes, and pH assays that can screen for pH change due to newly synthesized molecules using pH indicator on an agar plate. Substrate-induced gene expression screening (SIGEX), a method to screen for the expression of genes that are induced by chemical compounds, has also been used to search for genes with specific functions. Homology-based metagenomic studies have led to a fast discovery of genes that have homologous sequences as the previously known genes that are responsible for the biosynthesis of biologically active molecules. As soon as the genes are sequenced, scientists can compare thousands of bacterial genomes simultaneously. The advantage over functional metagenomic assays is that homology metagenomic studies do not require a host organism system to express the metagenomes, thus this method can potentially save the time spent on analyzing nonfunctional genomes.
The US Department of Agriculture (USDA) uses a figure of 6.93 kilocalories (29.0 kJ) per gram of alcohol (5.47 kcal or 22.9 kJ per mL) for calculating food energy. For distilled spirits, a standard serving in the United States is 44 mL (1.5 US fl oz), which at 40% ethanol (80 proof), would be 14 grams and 98 calories. Alcoholic drinks are considered empty calorie foods because other than food energy they contribute no essential nutrients. However, alcohol is a significant source of food energy for individuals with alcoholism and those who engage in binge drinking. For example, individuals with drunkorexia engage in the combination of self-imposed malnutrition and binge drinking. In alcoholics who get most of their daily calories from alcohol, a deficiency of thiamine (vitamin B1) can produce Korsakoff syndrome, which is associated with serious brain damage.
Sources: en.wikipedia.org
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence corresponds to a fragment of a protein found in human gastric juice. It is studied mainly in preclinical research and is not an approved pharmaceutical product in major markets. Materials sold for laboratory use are typically labelled as research chemicals.
No medicines regulator in the United States or the European Union has approved BPC-157 as a therapeutic product. Presenting it as a drug or as a dietary supplement ingredient would generally not match its regulatory status. Availability as a research chemical does not imply clinical approval.
Published reports rest largely on animal models and cell culture rather than controlled human trials. Review articles describe the proposed mechanisms as incompletely understood. Conclusions about effects in humans therefore remain tentative.
Human data are limited. Most evidence comes from animal experiments and from small or uncontrolled reports. The absence of large trials means clinical effects and safety are not firmly established.